Grace Capital’s Biogen BIIB Stock Holding History

Grace Capital’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$312K	Hold	1,300	–	–	0.19%	112
2021 Q3	$351K	Buy	1,300 +200	+18%	+$65.5K	0.22%	115
2021 Q2	$381K	Sell	1,100 -250	-19%	-$75.7K	0.26%	101
2021 Q1	$378K	Hold	1,350	–	–	0.24%	113
2020 Q4	$331K	Hold	1,350	–	–	0.21%	117
2020 Q3	$382K	Sell	1,350 -900	-40%	-$251K	0.3%	85
2020 Q2	$602K	Hold	2,250	–	–	0.52%	55
2020 Q1	$712K	Sell	2,250 -500	-18%	-$152K	0.7%	46
2019 Q4	$816K	Sell	2,750 -400	-13%	-$111K	0.67%	36
2019 Q3	$733K	Buy	3,150 +400	+15%	+$93.1K	0.74%	33
2019 Q2	$643K	Hold	2,750	–	–	0.31%	85
2019 Q1	$650K	Sell	2,750 -700	-20%	-$220K	0.25%	103
2018 Q4	$1.04M	Buy	3,450 +700	+25%	+$223K	0.48%	69
2018 Q3	$973K	Sell	2,750 -6,500	-70%	-$2.24M	0.38%	69
2018 Q2	$798K	Buy	9,250 +4,546	+97%	+$1.28M	0.3%	82
2018 Q1	$1.25M	Buy	4,704 +2,104	+81%	+$653K	0.67%	48
2017 Q4	$828K	Buy	+2,600	New	+$834K	0.29%	63

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Grace Capital's BIIB Position: Q4 2021 in Review

Grace Capital held its Biogen (BIIB) position steady in Q4 2021 at 1,300 shares worth $312K. The position accounts for 0.19% of the portfolio, ranked #112.

Grace Capital first reported a position in BIIB in Q4 2017 and has held it in 17 quarters since. The position peaked at $1.25M in Q1 2018. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q4 2021.

Grace Capital held 1,300 shares of Biogen worth $312K as of Q4 2021.
Grace Capital left its Biogen share count unchanged in Q4 2021.
Biogen made up 0.19% of Grace Capital's portfolio in Q4 2021, its #112 holding.
Grace Capital first reported a position in Biogen in Q4 2017 and has held it in 17 quarters since.
Grace Capital's Biogen position peaked at $1.25M in Q1 2018.
1,009 funds tracked by Wall St. Rank held Biogen as of Q4 2021.

Based on Grace Capital's 13F filing for Q4 2021, filed 2 Feb 2022.